Literature DB >> 16445161

Olfactory function in people with genetic risk of dementia.

R Salerno-Kennedy1, S Cusack, K D Cashman.   

Abstract

BACKGROUND: Screening for sensorial impairment is a secondary objective in the context of neurodegenerative diseases, including dementias. For example, olfactory dysfunction is among the first signs of Alzheimer's disease. There has been no study of olfactory function in Irish subjects at risk of dementia. AIM: To investigate olfactory function in non-demented Irish persons, who carry genetic risk factors for dementia.
METHODS: Thirty-eight Irish adult subjects, who are at risk of dementia, were recruited. Cognitive performance and olfactory function were assessed and apolipoprotein E (APOE) genotype determined.
RESULTS: Three and six subjects had a Mini Mental State Examination (MMSE) and Brief Smell Identification Test (B-SIT) score, respectively, outside the normal range. While five out of the fifteen epsilon-4 allele positive subjects had B-SIT scores outside the normal range, only one out of the twenty-three epsilon-4 allele negative subjects had; the difference in this frequency was significant (P=0.025). There was no significant difference (P=0.266) in the frequency of abnormal MMSE scores between epsilon-4 allele groups.
CONCLUSION: Further investigation is required to explore the reasons for the higher prevalence of olfactory dysfunction in epsilon-4 allele positive subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16445161     DOI: 10.1007/BF03168982

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  33 in total

Review 1.  Loss of olfactory function in dementing disease.

Authors:  C Murphy
Journal:  Physiol Behav       Date:  1999-04

Review 2.  Olfactory capacities in aging and Alzheimer's disease. Psychophysical and anatomic considerations.

Authors:  R L Doty
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Apolipoprotein E epsilon 4 and fatal cerebral amyloid angiopathy associated with dementia pugilistica.

Authors:  B D Jordan; A B Kanik; M S Horwich; D Sweeney; N R Relkin; C K Petito; S Gandy
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

Review 4.  [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].

Authors:  J M Norès; B Biacabe; P Bonfils
Journal:  Ann Med Interne (Paris)       Date:  2000-03

5.  Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.

Authors:  D P Devanand; K S Michaels-Marston; X Liu; G H Pelton; M Padilla; K Marder; K Bell; Y Stern; R Mayeux
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

6.  Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia.

Authors:  T Rodriguez Martin; A M Calella; S Silva; E Munna; P Modena; R Chiesa; S Terrevazzi; R M Ruggieri; R Palermo; F Piccoli; R Confalonieri; P Tiraboschi; C Fragiacomo; P Quadri; U Lucca; G Forloni
Journal:  Dement Geriatr Cogn Disord       Date:  2000 Sep-Oct       Impact factor: 2.959

7.  The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period.

Authors:  Robert S Wilson; Julie A Schneider; Lisa L Barnes; Laurel A Beckett; Neelum T Aggarwal; Elizabeth J Cochran; Elizabeth Berry-Kravis; Julie Bach; Jacob H Fox; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2002-07

8.  Olfactory function in apoE knockout mice.

Authors:  Britto P Nathan; Johnathan Yost; Melissa T Litherland; Robert G Struble; Paul V Switzer
Journal:  Behav Brain Res       Date:  2004-04-02       Impact factor: 3.332

9.  Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT).

Authors:  R L Doty; A Marcus; W W Lee
Journal:  Laryngoscope       Date:  1996-03       Impact factor: 3.325

10.  MMSE items predict cognitive decline in persons with genetic risk for Alzheimer's disease.

Authors:  Linda M Ercoli; Prabha Siddarth; Jennifer J Dunkin; Jennifer Bramen; Gary W Small
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-06       Impact factor: 2.680

View more
  3 in total

1.  Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome.

Authors:  W S Layman; D P McEwen; L A Beyer; S R Lalani; S D Fernbach; E Oh; A Swaroop; C C Hegg; Y Raphael; J R Martens; D M Martin
Journal:  Hum Mol Genet       Date:  2009-03-11       Impact factor: 6.150

2.  Olfactory impairment in presymptomatic Alzheimer's disease.

Authors:  Robert S Wilson; Steven E Arnold; Julie A Schneider; Patricia A Boyle; Aron S Buchman; David A Bennett
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

3.  Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.

Authors:  Rosebud O Roberts; Teresa J H Christianson; Walter K Kremers; Michelle M Mielke; Mary M Machulda; Maria Vassilaki; Rabe E Alhurani; Yonas E Geda; David S Knopman; Ronald C Petersen
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.